Achiko AG
OTC: ACHKF0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Other OTC
- Sector
- Healthcare
- Industry
- Medical - Healthcare Information Services
- CEO
- Wern-Yi Goh
- Employees
- 10
- Headquarters
- Zurich, Switzerland
- IPO year
- 2021
- Market cap
- $377.4K
- Website
- https://www.achiko.com
Loading ACHKF…
Loading profile data…Frequently asked questions about ACHKF
What does Achiko AG (ACHKF) do?
Achiko AG, established in 2018 and based in Zurich, Switzerland, focuses on pioneering diagnostic technologies for both Indonesian and international markets. Its flagship innovation is AptameX, a rapid diagnostic test that identifies the SARS-CoV-2 virus by utilizing DNA aptamers, distinguishing it from traditional antigen-based methods. The com...
Where does ACHKF trade?
Achiko AG (ACHKF) trades on the Other OTC.
What sector is ACHKF in?
Achiko AG (ACHKF) operates in the Healthcare sector, specifically in the Medical - Healthcare Information Services industry.
Who is the CEO of Achiko AG?
Wern-Yi Goh is the chief executive officer of Achiko AG (ACHKF).
Where is Achiko AG headquartered?
Achiko AG is headquartered in Switzerland.
Does ACHKF pay a dividend?
Achiko AG (ACHKF) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did ACHKF go public?
Achiko AG (ACHKF) completed its initial public offering in 2021.